[
  {
    "ts": "2025-09-12T22:01:28+00:00",
    "headline": "Stocks to Watch Friday: Adobe, Microsoft, Boeing, Warner Bros.",
    "summary": "↗️ Microsoft (MSFT): OpenAI and Microsoft reached a deal to extend their partnership, capping a summer of difficult negotiations. Shares rose nearly 2%. ↗️ Kenvue (KVUE): The interim CEO of the Tylenol maker had a private meeting with Robert F.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-09-12-2025/card/stocks-to-watch-friday-adobe-microsoft-warner-bros-alibaba-8SNZ8A8OoPNCKcTX9DkR?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "7c489e8c-ecc3-33fa-aaa0-7c1ea1c49eed",
      "content": {
        "id": "7c489e8c-ecc3-33fa-aaa0-7c1ea1c49eed",
        "contentType": "STORY",
        "title": "Stocks to Watch Friday: Adobe, Microsoft, Boeing, Warner Bros.",
        "description": "",
        "summary": "↗️ Microsoft (MSFT): OpenAI and Microsoft reached a deal to extend their partnership, capping a summer of difficult negotiations. Shares rose nearly 2%. ↗️ Kenvue (KVUE): The interim CEO of the Tylenol maker had a private meeting with Robert F.",
        "pubDate": "2025-09-12T22:01:28Z",
        "displayTime": "2025-09-12T22:01:28Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7c489e8c-ecc3-33fa-aaa0-7c1ea1c49eed/stocks-to-watch-friday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/940e232e091a2e5859bb087164e2b4fc",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pU_C8z6KMgd3akntgH2u6w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/940e232e091a2e5859bb087164e2b4fc.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/saFPKQW_JXBTagoMi7sbuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/940e232e091a2e5859bb087164e2b4fc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-09-12-2025/card/stocks-to-watch-friday-adobe-microsoft-warner-bros-alibaba-8SNZ8A8OoPNCKcTX9DkR?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "RH"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "BA"
            },
            {
              "symbol": "ADBE"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "WBD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T18:03:00+00:00",
    "headline": "CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report",
    "summary": "In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing there is no clear link.",
    "url": "https://www.wsj.com/health/pharma/ceo-of-tylenol-maker-lobbied-rfk-jr-not-to-cite-drug-as-autism-cause-in-report-45be9a46?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "855d59a2-030b-3a1a-b3ab-3efa3df05285",
      "content": {
        "id": "855d59a2-030b-3a1a-b3ab-3efa3df05285",
        "contentType": "STORY",
        "title": "CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report",
        "description": "",
        "summary": "In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing there is no clear link.",
        "pubDate": "2025-09-12T18:03:00Z",
        "displayTime": "2025-09-12T18:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/855d59a2-030b-3a1a-b3ab-3efa3df05285/ceo-of-tylenol-maker-lobbied.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/01eef0da6ab3632188706506d3f04f1b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iK00qYBKUrWqNZWMiIfDiA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/01eef0da6ab3632188706506d3f04f1b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/smQdvwu8z6uIUHfSO27ZPQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/01eef0da6ab3632188706506d3f04f1b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/ceo-of-tylenol-maker-lobbied-rfk-jr-not-to-cite-drug-as-autism-cause-in-report-45be9a46?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T15:35:15+00:00",
    "headline": "Top Midday Stories: FTC Probing Alphabet, Amazon Over Ad Placement Practices; IonQ Gets UK Regulatory Clearance for Oxford Acquisition",
    "summary": "The Dow Jones Industrial Average was down, while the S&P 500 and Nasdaq Composite were up in late-mo",
    "url": "https://finance.yahoo.com/news/top-midday-stories-ftc-probing-153515850.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "57487003-10cb-34fa-acbe-9cf03310e13c",
      "content": {
        "id": "57487003-10cb-34fa-acbe-9cf03310e13c",
        "contentType": "STORY",
        "title": "Top Midday Stories: FTC Probing Alphabet, Amazon Over Ad Placement Practices; IonQ Gets UK Regulatory Clearance for Oxford Acquisition",
        "description": "",
        "summary": "The Dow Jones Industrial Average was down, while the S&P 500 and Nasdaq Composite were up in late-mo",
        "pubDate": "2025-09-12T15:35:15Z",
        "displayTime": "2025-09-12T15:35:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-ftc-probing-153515850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-ftc-probing-153515850.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IONQ"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "ADBE"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T11:16:04+00:00",
    "headline": "Market Chatter: Kenvue CEO Sough to Prevent RFK Jr. From Citing Tylenol as Potential Autism Cause",
    "summary": "Kenvue's (KVUE) interim chief executive Kirk Perry had a private meeting with Robert F Kennedy Jr. t",
    "url": "https://finance.yahoo.com/news/market-chatter-kenvue-ceo-sough-111604071.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "e2c786dc-7264-3690-a6a7-9cc6087ebf5e",
      "content": {
        "id": "e2c786dc-7264-3690-a6a7-9cc6087ebf5e",
        "contentType": "STORY",
        "title": "Market Chatter: Kenvue CEO Sough to Prevent RFK Jr. From Citing Tylenol as Potential Autism Cause",
        "description": "",
        "summary": "Kenvue's (KVUE) interim chief executive Kirk Perry had a private meeting with Robert F Kennedy Jr. t",
        "pubDate": "2025-09-12T11:16:04Z",
        "displayTime": "2025-09-12T11:16:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-kenvue-ceo-sough-111604071.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/market-chatter-kenvue-ceo-sough-111604071.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-12T10:02:37+00:00",
    "headline": "Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports",
    "summary": "WSJ reported on September 5 that the U.S. health secretary planned to announce that the use of Tylenol, a popular over-the-counter pain medication, in pregnant women was potentially linked to autism - contrary to medical guidelines that say it is safe to use.  Until the final report is released, any claims about its findings are speculative, the U.S. Department of Health and Human Services said in an emailed response.",
    "url": "https://finance.yahoo.com/news/kenvue-ceo-lobbied-rfk-jr-100237169.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "ba734407-9333-3d33-a530-4e9fd12e2604",
      "content": {
        "id": "ba734407-9333-3d33-a530-4e9fd12e2604",
        "contentType": "STORY",
        "title": "Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports",
        "description": "",
        "summary": "WSJ reported on September 5 that the U.S. health secretary planned to announce that the use of Tylenol, a popular over-the-counter pain medication, in pregnant women was potentially linked to autism - contrary to medical guidelines that say it is safe to use.  Until the final report is released, any claims about its findings are speculative, the U.S. Department of Health and Human Services said in an emailed response.",
        "pubDate": "2025-09-12T10:02:37Z",
        "displayTime": "2025-09-12T10:02:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters-finance.com/fd84b886e4fed39460d0f79e43f27948",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4jc8cl_W1dMQRTupeGWnzA--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/fd84b886e4fed39460d0f79e43f27948.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hjTihfgo77bRFdPAGb7eew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/fd84b886e4fed39460d0f79e43f27948.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-ceo-lobbied-rfk-jr-100237169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-ceo-lobbied-rfk-jr-100237169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]